Home › Funds › Illumine Investment Management, LLC › VRTX
Illumine Investment Management, LLC position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Illumine Investment Management, LLC reported holding 5,782 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$2.6M, representing 1.98% of its reported portfolio and ranking #13 among its reported holdings. Illumine Investment Management, LLC has disclosed VRTX holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How Illumine Investment Management, LLC's VRTX position evolved
Illumine Investment Management, LLC first disclosed a stake in VRTX in Q4 2024 at 5,776 shares (US$2.3M). The position peaked in Q1 2025 at 5,854 shares, worth US$2.8M. Across 6 filings, Illumine Investment Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 5,782 shares valued at US$2.6M — a reduction of -38 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 5.78K | $2.33M | New |
| Q1 2025 | 5.85K | $2.84M | Add |
| Q2 2025 | 5.88K | $2.62M | Hold |
| Q3 2025 | 5.83K | $2.28M | Reduce |
| Q4 2025 | 5.82K | $2.64M | Hold |
| Q1 2026 | 5.78K | $2.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- LOOMIS SAYLES & CO L P 3.92M sh · $1.95B · Q2 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- Clearbridge Investments, LLC 2.34M sh · $1.16B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.17M sh · $1.08B · Q2 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on Illumine Investment Management, LLC
FAQ
How long has Illumine Investment Management, LLC held VRTX?
Illumine Investment Management, LLC has disclosed VRTX holdings in 6 of the last 6 reported quarters, going back to Q4 2024.
What is Illumine Investment Management, LLC's current position in VRTX?
As of Q1 2026, Illumine Investment Management, LLC holds 5.78K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $2.58M, representing 1.98% of its reported portfolio and ranking #13.
Has Illumine Investment Management, LLC been buying or selling VRTX?
In the latest 13F filing (Q1 2026), Illumine Investment Management, LLC reduced its position in VRTX. The position peaked in Q1 2025 at 5.85K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.